Why it matters

Some eye diseases are particularly prevalent among certain demographics. For example, cataract – which is one of the world’s leading causes of blindness – is experienced by more than nine out of 10 over 80s*. But it is the collective burden of eye disease that is most stark. More than 2.2 billion people are believed to have a visual impairment** and eye disease is estimated to account for 4% of global disability-adjusted life years (DALYs)***. However, preventable or treatable eye diseases are prevalent in more than 90% of those with a vision impairment****. Successful research efforts are key to reducing or minimising the impact of eye diseases.

What we do

CROs operating in global ophthalmology research regularly partner with Woodley Trial Solutions to secure the clinical trials equipment they need to ensure the success of their projects. Many of our partnerships with ophthalmology researchers include agreements to supply fully calibrated centrifuges, with our expert and knowledgeable team able to recommend the most suitable equipment for a project’s specific requirements. Other agreements include the provision of refrigerators, freezers, thermometers, temperature dataloggers, and scales. Long-term and strategic investments in our warehousing and distribution networks mean equipment can be supplied anywhere in the world at just a few days’ notice.

Featured case study

Featured blog

Equipment for ophthalmology trials

Got a question?

Got a question?

Why partner with us?

Our 30+ years of experience with product knowledge, sourcing quality, regulatory intelligence and logistical knowhow makes us experts in what we do.

We take care of details – providing reassurance and saving you time and money from end-to-end of your clinical trial.

More about us

More therapeutic areas

See all therapeutic areas


* https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-14491-0
** https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
*** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920965/
**** https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30488-5/fulltext